Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Yervoy Injection launched in Japan

Aug. 31, 2015

Challenge award supports NantKwest's natural killer cell-based therapy for prostate cancer

Aug. 31, 2015

Enumeral Biomedical gains access to ipilimumab patient samples

Aug. 28, 2015

Daratumumab gains third FDA orphan drug designation

Aug. 27, 2015

IDMC recommends reduction of cardiac toxicity monitoring in PRESENT trial

Aug. 25, 2015

Regeneron designs human antibodies to PD-1

Aug. 25, 2015

Peregrine and AstraZeneca collaborate to conduct bavituximab and durvalumab combination study

Aug. 24, 2015

Northwest Biotherapeutics confirms status of phase III trial of DCVax-L in glioblastoma multiforme

Aug. 24, 2015

Advaxis and MedImmune start phase I/II trial combining ADXS-HPV and durvalumab

Aug. 24, 2015

Prostate cancer vaccine MVI-816 enters phase I/II trial in combination with pembrolizumab

Aug. 20, 2015

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...